Description of Blood Analysis:

Fibrinogen, also known as Factor I, is a vital plasma protein produced by the liver that plays a central role in the blood coagulation process. When an injury occurs to a blood vessel, fibrinogen is converted into insoluble strands of fibrin, which act as the “mesh” that stabilizes a blood clot and stops bleeding. Beyond its role in clotting, fibrinogen is an acute-phase reactant, meaning its concentration in the blood rises significantly in response to tissue inflammation, trauma, or infection. This test measures the amount of this protein available to help your body manage both healing and systemic inflammatory responses.

What does the analysis represent?

• Purpose: To evaluate the concentration of fibrinogen available for clot formation and to assess systemic inflammation.
• Application: Diagnosing bleeding disorders, evaluating the risk of cardiovascular events, and monitoring the progression of inflammatory diseases.
• Method: A quantitative assay, typically the Clauss method, which measures the rate of clot formation after adding a standard amount of thrombin to plasma.

Recommendations for the Test (General)

• Timing: The blood sample should ideally be collected during the morning hours.
• Fasting: A fasting period of 8–12 hours is recommended to ensure that the plasma is clear and free from interference by dietary fats.
• Hydration: Drinking plain, non-carbonated water is permitted and helps ensure a successful blood draw.
• Preparation: Avoid alcohol and strenuous physical activity for at least 24 hours before the test, as these can temporarily alter protein levels.

What can affect the results?

• Physiological States: Pregnancy naturally increases fibrinogen levels as the body prepares for the blood loss associated with childbirth.
• Medications: The use of oral contraceptives, hormone replacement therapy, or certain cholesterol-lowering drugs can cause fluctuations in the results.
• Lifestyle and Health: Smoking and obesity are often associated with chronically elevated fibrinogen levels, while severe liver disease can lead to a significant decrease in production.

When to take the test?

• Bleeding Investigations: If a patient experiences prolonged bleeding or has abnormal results in basic screening tests like PT or PTT.
• Surgical Clearance: To ensure the body has sufficient protein levels to form stable clots during and after an invasive procedure.
• Risk Assessment: To help determine a patient’s risk for developing cardiovascular disease, as high fibrinogen is linked to increased blood viscosity and arterial issues.

How to interpret the results?

The interpretation of fibrinogen levels is the exclusive responsibility of a qualified physician. Elevated levels are frequently seen during acute infections or inflammatory states, whereas low levels may indicate that the body is consuming the protein too quickly (as in DIC) or not producing enough due to liver dysfunction. Because fibrinogen reacts to so many different bodily stresses, a physician must compare the result with other markers of inflammation and clotting to determine the specific cause of any abnormality.

Possible further investigations

• C-Reactive Protein (CRP): To differentiate whether high fibrinogen is caused by general inflammation.
• D-Dimer: To check if the body is actively breaking down a large number of clots.
• Liver Function Panel: To evaluate the organ’s ability to synthesize essential clotting proteins.

When does the next step make sense? 

A fibrinogen test is often a critical piece of the puzzle when investigating complex health issues. If the results are abnormal, the next step usually involves identifying the source of inflammation or addressing a deficiency in the clotting system. Regular monitoring may be advised for patients with chronic inflammatory conditions or those at a high risk for thrombosis to help guide preventative care and treatment adjustments.

👉 If necessary, you can discuss the test results with a specialist, such as hematologist (Doctors – TAMC).